Kentuckiana Cancer Institute
Closed portfolio with an early-phase archive tilt
According to ClinicalTrials.gov-derived indexes, Kentuckiana Cancer Institute sits in the upper quartile of US sponsors by registered trial count (#2,411 of 15,742 sponsors by registered trial count).
Kentuckiana Cancer Institute: 5 sponsored US clinical trials, none currently recruiting.
Kentuckiana Cancer Institute sponsors 5 registered US clinical trials on ClinicalTrials.gov, none currently recruiting, and 3 completed. 0 of these trials are in Phase 3-4 (later-stage) and 2 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Adult-Onset Glioma, with 1 trials.
Upper-quartile sponsor footprint
Kentuckiana Cancer Institute sits in the upper quartile of the sponsor corpus (#2,411 of 15,742 sponsors by registered trial count) - denser than most sponsors, still short of the top-decile hubs.
Indexed trials (enrollment closed)
5 total, page 1 of 1
Genetic Epidemiology of Adult Onset Glioma
NCT00283569
Iscar for Second Line Treatment of Advanced Non-Small Cell Lung Cancer
NCT00283478
Docetaxel, Irinotecan, and Carboplatin in Extensive Stage Non-Small Cell Lung Cancer
NCT00264134
Tumor Phenotypes and Correlation to Clinical Outcomes in Cancer
NCT00283530
High Dose Camptothecin-11 (CPT-11) in Recurrent Unresectable Malignant Glioma
NCT00283556
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 2 |
Therapeutic Areas
How the Kentuckiana Cancer Institute early-phase archive is shaped
5 indexed studies, none listed as recruiting (0% open); 3 completed (60%).
Phase mix: 0 late (III/IV) vs 2 early (I/II) (early-phase heavy).
Top condition: Adult-Onset Glioma (1 trial), 0 others listed.
How to read a closed sponsor archive
When recruiting_count is zero, the indexed set is completed or otherwise not open. Phase tilt still describes where archived studies sat on the investigational pathway. Re-check ClinicalTrials.gov before acting.
Kentuckiana Cancer Institute: archived-pipeline peers nationwide
Peers matched on 5 indexed studies with no current recruiting: volume and archive shape, not condition overlap.
Kentuckiana Cancer Institute sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 5 archived trials
- 4YouandMe · 5 trials · 0% recruiting
- Abbott Rapid Dx · 5 trials · 0% recruiting
- Access Business Group · 5 trials · 0% recruiting
- Acera Surgical · 5 trials · 20% recruiting
Sponsors with similar archive density (± trial count)
- 10xBio · 0% recruiting · 3 trials
- 22nd Century Group · 0% recruiting · 3 trials
- 23andMe · 0% recruiting · 6 trials
- 3-C Institute for Social Development · 0% recruiting · 14 trials
Related
What to do with this Kentuckiana Cancer Institute page
5 registered trials is a research-attention snapshot, not an endorsement of Kentuckiana Cancer Institute or any single study.
- None of Kentuckiana Cancer Institute's trials are currently recruiting in this registry; that can change as new trials post, or check the broader research index. Browse research indexes
- Adult-Onset Glioma is the condition Kentuckiana Cancer Institute studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Adult-Onset Glioma trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. Kentuckiana Cancer Institute pipeline card: 5 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.